Allergan Aesthetics, a subsidiary of AbbVie, is showcasing its latest innovations at the Anti-Aging and Aesthetics Medicine World Congress (AMWC) in Monaco from March 27 to March 29, 2025. The company is introducing the AA Signature program, which aims to enhance patient treatment outcomes by utilizing Allergan's advanced portfolio.
The event will feature several expert-led sessions, including symposia hosted by the Allergan Medical Institute (AMI). These will highlight the new AA Signature program and celebrate a decade of MD Codes. The first symposium titled "Design your patients' look with the NEW Signature approach by Allergan Aesthetics" will be chaired by Dr. Stefania Roberts and Dr. Andre Braz. It will include live injection sessions with experts such as Dr. Sylwia Lipko-Godlewska and Dr. Marcel Vinicius.
Another key session is "MD Codes and Allergan Aesthetics: a decade of excellence and a signature of success for the future," led by Dr. Maurício de Maio among others. This session will explore the global impact of MD Codes and discuss hyaluronic acid's role in modern treatment approaches.
Additional events include the Science of AgingTM Symposium featuring discussions on skin longevity and aging genomics, chaired by Dr. Stephanie Manson Brown and Dr. Patricia Ogilvie. The Global Aesthetics Medical Affairs Symposium will address how aesthetic treatments affect emotional well-being, led by Dr. Steven Dayan.
Attendees can also participate in Meet the Experts sessions at the Allergan booth, covering topics like skin quality improvement and periorbital treatment strategies.
Allergan Aesthetics is presenting 11 E-Posters showcasing recent scientific advancements supporting its brand portfolio, focusing on areas such as skin quality lexicon development and eye rejuvenation studies.
For more information about AbbVie or Allergan Aesthetics' offerings, visit their respective websites or follow them on social media platforms.